Multi-omic analysis identifies hypoalbuminemia as independent biomarker of poor outcome upon PD-1 blockade in metastatic melanoma
Leek, Lindsay V. M., Notohardjo, Jessica C. L., de Joode, Karlijn, Velker, Eline L., Haanen, John B. A. G., Suijkerbuijk, Karijn P. M., Aarts, Maureen J. B., de Groot, Jan Willem B., Kapiteijn, Ellen, van den Berkmortel, Franchette W. P. J., Westgeest, Hans M., de Gruijl, Tanja D., Retel, Valesca P., Cuppen, Edwin, van der Veldt, Astrid A. M., Labots, Mariette, Voest, Emile E., van de Haar, Joris, van den Eertwegh, Alfons J. M.
Published in Scientific reports (16.05.2024)
Published in Scientific reports (16.05.2024)
Get full text
Journal Article
Efficacy of pembrolizumab and biomarker analysis in patients with WGS-based intermediate to high tumor mutational load: results from the Drug Rediscovery Protocol
Geurts, Birgit S, Zeverijn, Laurien J, Leek, Lindsay V M, van Berge Henegouwen, Jade M, Hoes, Louisa R, van der Wijngaart, Hanneke, van der Noort, Vincent, van de Haar, Joris, van Ommen-Nijhof, Annemiek, Kok, Marleen, Roepman, Paul, Jansen, Anne M L, de Leng, Wendy W J, de Jonge, Maja J A, Hoeben, Ann, van Herpen, Carla M L, Westgeest, Hans M, Wessels, Lodewyk F A, Verheul, Henk M W, Gelderblom, Hans, Voest, Emile E
Published in Clinical cancer research (03.09.2024)
Published in Clinical cancer research (03.09.2024)
Get full text
Journal Article
Limited clinical activity of palbociclib and ribociclib monotherapy in advanced cancers with cyclin D‐CDK4/6 pathway alterations in the Dutch DRUP and Australian MoST trials
Zeverijn, Laurien J., Looze, Eleonora J., Thavaneswaran, Subotheni, Berge Henegouwen, J. Maxime, Simes, Robert J., Hoes, Louisa R., Sjoquist, Katrin M., Wijngaart, Hanneke, Sebastian, Lucille, Geurts, Birgit S., Lee, Chee K., Wit, Gijsbrecht F., Espinoza, David, Roepman, Paul, Lin, Frank P., Jansen, Anne M. L., Leng, Wendy W. J., Noort, Vincent, Leek, Lindsay V. M., Vos, Filip Y. F. L., Herpen, Carla M. L., Gelderblom, Hans, Verheul, Henk M. W., Thomas, David M., Voest, Emile E.
Published in International journal of cancer (01.10.2023)
Published in International journal of cancer (01.10.2023)
Get full text
Journal Article
The Innate Immune Landscape of dMMR/MSI Cancers Predicts the Outcome of Nivolumab Treatment: Results from the Drug Rediscovery Protocol
Zeverijn, Laurien J, Geurts, Birgit S, Battaglia, Thomas W, van Berge Henegouwen, Jade M, de Wit, Gijs F, Hoes, Louisa R, van der Wijngaart, Hanneke, van der Noort, Vincent, Roepman, Paul, de Leng, Wendy W J, Jansen, Anne M L, Chalabi, Myriam, van Herpen, Carla M L, Devriese, Lot A, Erdkamp, Frans L G, Labots, Mariette, de Jonge, Maja J A, Kerver, Emile D, Bins, Adriaan D, Leek, Lindsay V M, Notohardjo, Jessica C L, van den Eertwegh, Alfonsus J M, Wessels, Lodewyk F A, Verheul, Henk M W, Gelderblom, Hans, van de Haar, Joris, Voest, Emile E
Published in Clinical cancer research (01.10.2024)
Published in Clinical cancer research (01.10.2024)
Get full text
Journal Article